Secondary prevention of colorectal cancer conducted by the Italian League for the Fight against Cancer in the Province of Latina, Italy. Preliminary results
Keywords:
colorectal cancer, early diagnosis, diagnostic procedures, secondary preventionAbstract
Colorectal cancer is one of the “big killers” of the western world. Despite the significant progress seen in surgical and radiotherapic techniques, as well as in chemotherapy both in the adjuvant phase and in the advanced stages of disease, still today many patients diagnosed later than the I stage of disease die due to relapse or progression of the disease. Secondary prevention thus remains an important instrument in reducing mortality due to this neoplasm. From 2000 to 2007, the Provincial Section in Latina of the Italian League for the Fight against Cancer (Lega Italiana per la Lotta contro i Tumori = LILT) conducted a screening campaign for this pathology, inviting close relatives of patients operated for colorectal cancer to undergo a colonoscopy. Of the 501 people examined, we found 98 adenomas (19.5%) and 18 carcinomas (3.5%), giving an overall total of 116 cases of neoplasia (23%). Proliferative lesions underwent biopsy and, when possible, endoscopic excision. No complications have been observed following this method. Our data are in line with those in the literature and confirm that this subset of the population is at risk for proliferative pathologies of the colon, and furthermore confirms that colonoscopy is the method of choice for the diagnosis and treatment of adenomatous lesions.
Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.